Semaglutide peptide studies represent a rapidly evolving field, centering on the analysis of GLP-1’s functions and its potential uses in addressing various chronic diseases . Initial work underscored its exceptional efficacy in controlling non-insulin dependent diabetic conditions, but current explorations are expanding to include its effect on b